Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMicrosaic Regulatory News (MSYS)

Share Price Information for Microsaic (MSYS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.05
Bid: 1.00
Ask: 1.10
Change: -0.07 (-6.25%)
Spread: 0.10 (10.00%)
Open: 1.05
High: 1.05
Low: 1.05
Prev. Close: 1.12
MSYS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Exclusive US and Canada Distribution Agreement

7 Nov 2018 07:00

RNS Number : 5382G
Microsaic Systems plc
07 November 2018
 

7 November 2018

Microsaic Systems plc

 

("Microsaic" or the "Company")

 

Exclusive US and Canada Distribution Agreement with Spark Holland Inc doing business as iChrom Solutions

 

Microsaic Systems plc (AIM: MSYS), the developer of point of need mass spectrometry ("MS") instruments, is pleased to announce that it has signed an exclusive distribution agreement with Spark Holland Inc doing business as iChrom Solutions ("iChrom") to distribute Microsaic-branded 4500 MiD® MS detector in the US and Canada.

 

As a full-service instrument distributor, iChrom serves several industries including drugs of abuse (DOA), clinical chemistry, and drug development in both the small molecule pharmaceutical area and protein characterization. iChrom's targeted industries include environmental toxicology and forensic/DOA toxicology testing.

 

iChrom has developed strategic partner relationships with several global instrument and consumable suppliers to expand offerings for a more comprehensive portfolio of high-quality instruments and accessories. These notable partners include Knauer Wissenschaftliche Geraete GmbH, Spark Holland BV, Axel Semrau GmbH & Co. KG, DataApex and American Chromatography. The combination of iChrom's instrument portfolio focus and its expertly trained staff delivers a dedicated and bespoke service with a successful track record.

 

Glenn Tracey, CEO of Microsaic, commented, "I am extremely pleased to partner with iChrom to distribute our compact, point of need MS technology, alongside their impressive technology portfolio. The team at iChrom has the in-depth technical expertise, and full reach of end user applications, particularly in drugs of abuse and small molecule pharmaceuticals.

 

"Clearly, North America is a well-established market for analytical chemistry, and this marks another milestone in what we expect to be a very exciting period of growth for Microsaic, now with seven distribution and OEM agreements signed in 2018 across North America, Europe, China, Taiwan and Malaysia"

 

John Crutchfield, President of iChrom, added: "The added sensitivity and selectivity provided by the unique design of the 4500 MiD MS detector offers our diverse clientele more flexibility in the types of samples they can analyze. Combined with our other hyphenated chromatography techniques of UHPLC, online SPE, and advanced sample processing, we now provide our clients with a fully automated analytical system capable of handling some of the most challenging sample matrices in the marketplace."

 

Enquiries:

 

 

Microsaic Systems plc

Glenn Tracey, CEO

Bevan Metcalf, FD

+44 (0) 1483 751 577

 

N+1 Singer (Nominated Adviser & Broker)

Shaun Dobson (Corporate Finance)

Tom Salvesen (Corporate Broking)

 

 

+44 (0)20 7496 3000

IFC Advisory Ltd (Financial PR)

Graham Herring

Heather Armstrong

Florence Chandler

+44 (0)20 3934 6630

 

 

About Microsaic Systems

Microsaic Systems plc (AIM: MSYS) is a high technology company developing chip-based, bench-top and point-of-analysis mass spectrometry ("MS") instruments that are designed to improve the efficiency of pharmaceutical R&D and manufacturing. The Company is working with established global life science companies to co-develop new solutions to improve productivity in the development of small molecule and novel biologic (peptides, antibodies) medicines. MS is a powerful method of analysis to enable earlier decision making relating to product identification, purity and bioactivity, and is the analytical technique of choice for biochemists across many industry sectors.

 

Microsaic's core product, the 4500 MiD®, is a robust and compact MS system, retaining the functionality of larger conventional MS systems, is easier to use by non-specialists, consumes less energy and has lower running costs. For more information, please go to www.microsaic.com.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGRQQLFBVFFXFBE
Date   Source Headline
27th Mar 20248:49 amRNSCompany Update
16th Feb 20247:00 amRNSCompany Update
25th Jan 20247:00 amRNSCompletion of Acquisition
23rd Jan 20241:30 pmRNSHolding(s) in Company
18th Jan 20246:15 pmRNSHolding(s) in Company
18th Jan 20243:15 pmRNSHolding(s) in Company
18th Jan 202412:00 pmRNSHolding(s) in Company
18th Jan 202410:05 amRNSHolding(s) in Company
16th Jan 20247:30 amRNSRestoration - Microsaic Systems PLC
16th Jan 20247:00 amRNSHalf-year Report
16th Jan 20247:00 amRNSFinal Results
16th Jan 20247:00 amRNSRestoration & Update
15th Jan 20243:45 pmRNSConditional Placing
12th Jan 20244:15 pmRNSAcquisition, Update & Change of Registered Office
4th Jan 20247:00 amRNSUpdate
29th Dec 202311:41 amRNSResult of General Meeting
22nd Dec 20231:27 pmRNSAcquisition & Fundraise Update, Revised Timetable
20th Dec 20233:03 pmRNSUpdate on Prospective Acquisition, Fundraise & GM
20th Dec 202312:30 pmRNSUpdate on Prospective Acquisition, Fundraise & GM
14th Dec 20237:00 amRNSUpdate on Financing, GM & Prospective Acquisition
4th Dec 20237:00 amRNSPublication of Circular and Notice of GM
13th Nov 20238:42 amRNSFunding Update
6th Nov 20237:00 amRNSFunding & Operational Update, Intention to Delist
3rd Nov 20231:32 pmRNSFunding & Operational Update, Intention to Delist
25th Sep 20237:00 amRNSUpdate and Directorate change
3rd Jul 20237:30 amRNSSuspension - Microsaic Systems PLC
29th Jun 20234:00 pmRNSAnnual Financial Report
26th Jun 20237:15 amRNSDeepVerge: debtor update
15th May 20237:15 amRNSAudit update
18th Apr 20237:59 amRNSDeepVerge plc debtor
13th Mar 202310:10 amRNSHolding(s) in Company
28th Dec 20229:25 amRNSHolding(s) in Company
24th Nov 20222:05 pmRNSSecond Price Monitoring Extn
24th Nov 20222:00 pmRNSPrice Monitoring Extension
30th Sep 20227:00 amRNSHalf-year Report
13th Sep 20227:25 amRNSSupply of mass spectroscopy services to DeepVerge
22nd Aug 20227:00 amRNSPartnership with Kingfield Electronics
5th Jul 20224:41 pmRNSSecond Price Monitoring Extn
5th Jul 20224:35 pmRNSPrice Monitoring Extension
5th Jul 20222:06 pmRNSSecond Price Monitoring Extn
5th Jul 20222:01 pmRNSPrice Monitoring Extension
4th Jul 20224:43 pmRNSReplacement: Trading Update
1st Jul 20222:09 pmRNSHolding(s) in Company
30th Jun 202212:11 pmRNSResult of AGM
30th Jun 20227:00 amRNSTrading Update
1st Jun 20227:00 amRNSPosting of Annual Report & Notice of AGM
30th May 20227:00 amRNSFinal Results
19th Apr 20227:00 amRNSManufacturing Services Framework Agreement
28th Mar 20227:30 amRNSUpdate on Microsaic's miniaturised technology
15th Mar 20227:00 amRNSBoard Appointment and Strategic Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.